Endo ERN
Find an expert
Ukraine
Endo ERN
Search
  • Rare Endocrine Conditions

    Endocrine Conditions

    Endo-ERN is focused on 8 main thematic groups (MTGs) which cover rare and/or complex endocrine conditions

    Go to overview

    Categories

    • MTG1Adrenal
    • MTG2Disorders of Calcium & Phosphate Homeostasis
    • MTG3Genetic Disorders of Glucose & Insulin Homeostasis
    • MTG4Genetic Endocrine Tumour Syndromes
    • MTG5Growth & Genetic Obesity Syndromes
    • MTG6Hypothalamic and Pituitary Conditions
    • MTG7Sex Development & Maturation
    • MTG8Thyroid
  • About Us

    About Us

    Endo-ERN is a network of 100+ Reference Centres (RCs) in 27 EU member states+Norway that offers access to clinical experts for patients with rare endocrine conditions.  

    Go to overview

    Who we are

    • About Endo-ERN
    • What we do
    • Reference centres
    • Work packages
    • Project team

    Information

    • Events
    • FAQ
    • Newsletter
    • Contact
    • ERNs
  • For Professionals

    For Professionals

    Endo-ERN is the network for rare endocrine conditions providing healthcare professionals with access to a variety of resources to support patient care.  

    Our Network

    • About Endo-ERN
    • Find a Reference Centre

    Research

    • Registries
    • Publications
    • Clinical Trials

    Support Tools

    • Virtual Consultations
    • Guidelines
    • COVID-19

    Training & Education

    • Webinars
    • Exchange Programme
  • For Members

    For Members

    If you work at a member institution this page will help with your Endo-ERN contributions.  

    Go to overview

    Quick Links

    • Cite Endo-ERN
    • CPMS 2.0
    • GA2026
    • The Journal

    Evaluation

    • Continuous Monitoring Exercise
    • 5-year evaluation
    • HCP Performance System

    Network Participation

    • Event Endorsement
    • Member Survey
    • Webinar Planning
    • MTG Representatives

    Membership Management

    • Update Member Contacts
    • Request Disease Area Expansion
    • Termination Policy
  • For Patients

    For Patients

    Access to rare disease expertise without the need to travel is a core ERN objective.  Our ePAGs contribute to all Endo-ERN activities.  

    Go to overview

    Patient information

    • What are European Reference Networks?
    • Cross-border healthcare
    • Rare endocrine conditions
    • Patient materials

    ePAG information

    • European Patient Advocacy Groups
    • Patient representatives
    • How to become an Endo-ERN ePAG
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
Endo ERN
Ukraine
Find an expert
Search
/ Publications Overview / Publications Database

Endo-ERN Publications Database

RDD IssuesBack to Publications Overview

Filter list of publications

940 publication(s) found matching the search criteria

Multicenter Analysis of Presacral Neuroendocrine Neoplasms—Clinicopathological Characterization and Treatment Outcomes of a Rare Disease


Author(s): Matrood S, Apostolidis L, Schrader J, Krug S, Lahner H, Ramaswamy A, Librizzi D, Kender Z, Kröcher A, Kreutzfeldt S, Gress TM, Rinke A
Affiliated Institution / ERN: ERN BOND ;
Condition / Disease: Neuroendocrine Neoplasms
Publication: Frontiers in Endocrinology v12 Year: 2021 ORPHAcode / other: ORPHA877
DOI: 10.3389/fendo.2021.709256 Keywords: CUP-NET,PRRT,carcinoid,neuroendocrine carcinoma,neuroendocrine tumor,presacral,prognosis,retrorectal

Association between long term exposure to particulate matter and incident hypertension in Spain


Author(s): Doulatram-Gamgaram V, Valdés S, Maldonado-Araque C, Lago-Sampedro A, Badía-Guillén R, García-Escobar E, García-Serrano S, García-Vivanco M, Garrido JL, Theobald MR, Gil V, Martín-Llorente F, Calle-Pascual A, Bordiu E, Castaño L, Delgado E, Franch-Nadal J, Chaves FJ, Montanya E, Galán-García JL, Aguilera-Venegas G, Soriguer F, Rojo-Martínez G
Affiliated Institution / ERN:
Condition / Disease: Hypertension
Publication: Scientific Reports v11.1 Year: 2021 ORPHAcode / other:
DOI: 10.1038/s41598-021-99154-7 Keywords:

A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score


Author(s): Parasiliti-Caprino M, Bioletto F, Frigerio T, D’Angelo V, Ceccato F, Ferraù F, Ferrigno R, Minnetti M, Scaroni C, Cannavò S, Pivonello R, Isidori A, Broglio F, Giordano R, Spinello M, Grottoli S, Arvat E
Affiliated Institution / ERN: AO City of Health and Science - Turin ; University Hospital of Padova ; AOU polyclinic "G.Martino" of Messina ; AOU Federico II - Naples ;
Condition / Disease: Cushing syndrome
Publication: Frontiers in Endocrinology v12 Year: 2021 ORPHAcode / other: ORPHA553
DOI: 10.3389/fendo.2021.747549 Keywords: adrenal disease,adrenocorticotrophic hormone,corticosteroids,cortisol,hypercortisolism,pituitary disease
MTG1 MTG6

Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group


Author(s): Bakhuizen JJ, Hanson H, van der Tuin K, Lalloo F, Tischkowitz M, Wadt K, Jongmans MCJ, Dörgeloh BB, Farah RA, Glentis S, Golmard L, Hoyer J, Jahnukainen K, Jewell R, Karow A, Katsibardi K, Kuhlen M, Meinhardt A, Nemes K, Poluha A, Ripperger T, Waespe N, Adlard J, Ahmed M, Brennan B, Dabir T, Evans DG, Kelsey A, Kohut K, Kulkarni A, Murray A, Ong KR, Penn A, Semple T, Woodward ER, van Leeuwaarde RS, Littooij AS, Merks JHM, Rasmussen ÃK, van Santen HM, Smetsers SE
Affiliated Institution / ERN:
Condition / Disease:
Publication: Familial Cancer v20.4 p337-348 Year: 2021 ORPHAcode / other:
DOI: 10.1007/s10689-021-00264-y Keywords: Cancer predisposition syndrome,DICER1,Hereditary,Surveillance

Bone Quality as Measured by Trabecular Bone Score in Normocalcemic Primary Hyperparathyroidism


Author(s): Naciu AM, Tabacco G, Falcone S, Incognito GG, Chiodini I, Maggi D, Pedone C, Lelli D, Bilezikian JP, Napoli N, Manfrini S, Cesareo R, Palermo A
Affiliated Institution / ERN: IRCCS Auxologico Italian Institute - Milan ;
Condition / Disease: Hyperparathyroidism
Publication: Endocrine Practice v27.10 p992-997 Year: 2021 ORPHAcode / other: ORPHA181408
DOI: 10.1016/j.eprac.2021.04.884 Keywords: PTH,TBS,calcium,hyperparathyroidism,normocalcemic hyperparathyroidism,vertebral fractures
MTG2

Adrenal ganglioneuromas: a retrospective multicentric study of 104 cases from the COMETE network


Author(s): Deflorenne E, Peuchmaur M, Vezzosi D, Ajzenberg C, Brunaud L, Chevalier N, Christin-Maitre S, Decoudier B, Driessens N, Drui DD, Gilly O, Goudet P, Illouz F, Jublanc C, Lefebvre H, Lopez A, Lussey C, Morini A, Raffin-Sanson M, Raingeard I, Renoult-Pierre P, Storey C, Tabarin A, Vantyghem MC, Vidal-Petiot E, Baudin E, Bertherat J, Amar L
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Cochin ; CHU de Toulouse ; Hôpital Universitaire de Bruxelles (HUDERF-Erasme) ; CHU d'Angers ; Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ;
Condition / Disease: Multiple endocrine neoplasia type 2B
Publication: European Journal of Endocrinology v185.4 p463-474 Year: 2021 ORPHAcode / other: ORPHA247709
DOI: 10.1530/EJE-20-1049 Keywords:
MTG4

Myocardial Geometry and Dysfunction in Morbidly Obese Adolescents (BMI 35–40 kg/m2)


Author(s): Siurana JM, Ventura PS, Yeste D, Riaza-Martin L, Arciniegas L, Clemente M, Torres M, Amigó N, Giralt G, Roses-Noguer F, Sabate-Rotes A
Affiliated Institution / ERN: Hospital Universitari Vall d’Hebron ;
Condition / Disease: Obesity
Publication: The American Journal of Cardiology v157 p128-134 Year: 2021 ORPHAcode / other: 5B81.00
DOI: 10.1016/j.amjcard.2021.07.026 Keywords:
MTG5

Illness-related burden, personal resources and need for support in patients with acromegaly: Results of a focus group analysis


Author(s): Siegel S, Kirstein CF, Schröder B, Unger N, Kreitschmann-Andermahr I
Affiliated Institution / ERN: University Hospital Essen ;
Condition / Disease: Acromegaly
Publication: Growth Hormone & IGF Research v60-61 p101422 Year: 2021 ORPHAcode / other: ORPHA963
DOI: 10.1016/j.ghir.2021.101422 Keywords: Acromegaly,Coping,Focus group,Impairment,Quality of life
MTG6

Distinct Late-Night Salivary Cortisol Cut-Off Values for the Diagnosis of Hypercortisolism


Author(s): van Baal L, Wichert M, Zwanziger D, Dralle H, Weber F, Kreitschmann-Andermahr I, Führer D, Unger N
Affiliated Institution / ERN: Children's Clinical University Hospital, Riga ;
Condition / Disease: Cushing's disease, Cushing's syndrome
Publication: Hormone and Metabolic Research v53.10 p662-671 Year: 2021 ORPHAcode / other: ORPHA96253, ORPHA189427
DOI: 10.1055/a-1608-1720 Keywords:
MTG1 MTG6

Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial


Author(s): Vergeer RA, Postma MR, Schmidt I, Korsten-Meijer AG, Feijen RA, Kruijff S, Nagengast WB, van Dijk JMC, den Dunnen WFA, van Beek AP, Kuijlen JMA, van den Berg G
Affiliated Institution / ERN: University Medical Center Groningen ;
Condition / Disease: Pituitary adenoma
Publication: BMJ Open v11.10 pe049109 Year: 2021 ORPHAcode / other: ORPHA99408
DOI: 10.1136/bmjopen-2021-049109 Keywords: neurosurgery,pituitary disorders
MTG6

Gene expression signatures predict response to therapy with growth hormone


Author(s): Stevens A, Murray P, De Leonibus C, Garner T, Koledova E, Ambler G, Kapelari K, Binder G, Maghnie M, Zucchini S, Bashnina E, Skorodok J, Yeste D, Belgorosky A, Siguero JL, Coutant R, Vangsøy-Hansen E, Hagenäs L, Dahlgren J, Deal C, Chatelain P, Clayton P
Affiliated Institution / ERN: Public Pediatric Teaching Hospital ; Hôpital Universitaire de Bruxelles (HUDERF-Erasme) ; IRCCS Ospedale Policlinico San Martino – Genova ; Merkur University Hospital ; Karol Jonscher Clinical Hospital of Poznań University of Medical Sciences ; ERN BOND ;
Condition / Disease: Growth hormone deficiency, Turner syndrome
Publication: The Pharmacogenomics Journal v21.5 p594-607 Year: 2021 ORPHAcode / other: ORPHA631, ORPHA881
DOI: 10.1038/s41397-021-00237-5 Keywords:
MTG6 MTG7

Circulating adrenomedullin and B-type natriuretic peptide do not predict blood pressure fluctuations during pheochromocytoma resection: a cross-sectional study


Author(s): Berends AMA, Buitenwerf E, Riphagen IJ, Lenders JWM, Timmers HJLM, Kruijff S, Links TP, van der Horst-Schrivers ANA, Stegeman CA, Eekhoff EMW, Feelders RA, Corssmit EPM, Groote Veldman R, Haak HR, Muller Kobold AC, Kerstens MN
Affiliated Institution / ERN: University Hospital Essen ; Sestre milosrdnice University Hospital Center ; Universitätsklinikum Schleswig-Holstein ; Universitätsklinikum Tübingen ; University Hospital Aachen ; Ulm University Medical Center ;
Condition / Disease: Phaeochromocytoma and paraganglioma
Publication: European Journal of Endocrinology v185.4 p507-514 Year: 2021 ORPHAcode / other: ORPHA573163
DOI: 10.1530/EJE-20-1452 Keywords:
MTG1 MTG4

Molecular aspects and long-term outcome of patients with primary distal renal tubular acidosis


Author(s): Gómez-Conde S, García-Castaño A, Aguirre M, Herrero M, Gondra L, García-Pérez N, García-Ledesma P, Martín-Penagos L, Dall’Anese C, Ariceta G, Castaño L, Madariaga L
Affiliated Institution / ERN:
Condition / Disease:
Publication: Pediatric Nephrology v36.10 p3133-3142 Year: 2021 ORPHAcode / other:
DOI: 10.1007/s00467-021-05066-z Keywords: ATP6V0A4,ATP6V1B1,Distal renal tubular acidosis,Genotype-phenotype correlation,Growth,Long-term outcome,SLC4A1

Complications After Thyroidectomy in Children: Lymph Node Dissection Is a Risk Factor for Permanent Hypocalcemia


Author(s): van Rooijen JJ, van Trotsenburg ASP, van de Berg DJ, Zwaveling-Soonawala N, Nieveen van Dijkum EJM, Engelsman AF, Derikx JPM, Mooij CF
Affiliated Institution / ERN: Amsterdam UMC ;
Condition / Disease: Pediatric Graves disease; thyroid carcinoma;
Publication: Frontiers in Endocrinology v12 Year: 2021 ORPHAcode / other: ORPHA525731; ORPHA100088;
DOI: 10.3389/fendo.2021.717769 Keywords: Graves’ disease,hypocalcemia,postoperative complications,recurrent laryngeal nerve (RLN) injury,thyroid cancer,thyroidectomy
MTG8

Health-Related Quality of Life in Patients With Early-Detected Central Congenital Hypothyroidism


Author(s): Naafs JC, Marchal JP, Verkerk PH, Fliers E, van Trotsenburg ASP, Zwaveling-Soonawala N
Affiliated Institution / ERN:
Condition / Disease: Central congenital hypothyroidism
Publication: The Journal of Clinical Endocrinology & Metabolism v106.10 pe4231-e4241 Year: 2021 ORPHAcode / other: ORPHA226298
DOI: 10.1210/clinem/dgab209 Keywords: central hypothyroidism,congenital hypothyroidism,fatigue,neonatal screening,quality of life
MTG8

Implication of Heterozygous Variants in Genes of the Leptin–Melanocortin Pathway in Severe Obesity


Author(s): Courbage S, Poitou C, Le Beyec-Le Bihan J, Karsenty A, Lemale J, Pelloux V, Lacorte J, Carel J, Lecomte N, Storey C, De Filippo G, Coupaye M, Oppert J, Tounian P, Clément K, Dubern B
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin ; Hôpital Bicêtre ;
Condition / Disease: Genetic obesity
Publication: The Journal of Clinical Endocrinology & Metabolism v106.10 p2991-3006 Year: 2021 ORPHAcode / other: ORPHA77828
DOI: 10.1210/clinem/dgab404 Keywords: Severe early,leptin,melanocortin pathway,onset obesity
MTG5

Hypogonadism in Adult Males with Prader-Willi Syndrome—Clinical Recommendations Based on a Dutch Cohort Study, Review of the Literature and an International Expert Panel Discussion


Author(s): Pellikaan K, Ben Brahim Y, Rosenberg AGW, Davidse K, Poitou C, Coupaye M, Goldstone AP, Høybye C, Markovic TP, Grugni G, Crinò A, Caixàs A, Eldar-Geva T, Hirsch HJ, Gross-Tsur V, Butler MG, Miller JL, van den Berg SAA, van der Lely AJ, de Graaff LCG
Affiliated Institution / ERN: Erasmus MC: University Medical Center Rotterdam ; Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ; Karolinska University Hospital ; IRCCS Auxologico Italian Institute - Milan ;
Condition / Disease: Prader-Willi syndrome
Publication: Journal of Clinical Medicine v10.19 p4361 Year: 2021 ORPHAcode / other: ORPHA739
DOI: 10.3390/jcm10194361 Keywords: Prader-Willi syndrome,estrogens,hypogonadism,hypothalamus,menstrual cycle,obesity,pituitary gland,puberty
MTG5

Pathogenic and Low-Frequency Variants in Children With Central Precocious Puberty


Author(s): Neocleous V, Fanis P, Toumba M, Gorka B, Kousiappa I, Tanteles GA, Iasonides M, Nicolaides NC, Christou YP, Michailidou K, Nicolaou S, Papacostas SS, Christoforidis A, Kyriakou A, Vlachakis D, Skordis N, Phylactou LA
Affiliated Institution / ERN: Cyprus Institute of Neurology and Genetics ; General Hospital of Athens “LAIKO” ; Aghia Sophia Children’s Hospital ;
Condition / Disease: Central Precocious Puberty
Publication: Frontiers in Endocrinology v12 Year: 2021 ORPHAcode / other: ORPHA759
DOI: 10.3389/fendo.2021.745048 Keywords: DLK1,KISS1,KISS1R, MAGEL2,MKRN3,central precocious puberty,next-generation sequencing
MTG7

Diagnosis and Management of Central Congenital Hypothyroidism


Author(s): Lauffer P, Zwaveling-Soonawala N, Naafs JC, Boelen A, van Trotsenburg ASP
Affiliated Institution / ERN:
Condition / Disease: Central Congenital Hypothyroidism
Publication: Frontiers in Endocrinology v12 Year: 2021 ORPHAcode / other: ORPHA442
DOI: 10.3389/fendo.2021.686317 Keywords: central congenital hypothyroidism,combined pituitary hormone deficiencies,diagnosis,etiology,isolated central congenital hypothyroidism,management,pituitary stalk interruption syndrome
MTG8

90Y radioembolization in the treatment of neuroendocrine neoplasms: Results of an international multicenter retrospective study.


Author(s): Schaarschmidt BM, Wildgruber M, Kloeckner R, Nie J, Steinle V, Braat AJAT, Lohoefer F, Kim HS, Lahner H, Weber M, Theysohn J
Affiliated Institution / ERN: Children's Clinical University Hospital, Riga ; Azienda USL-IRCCS di Reggio Emilia ; CHU de Toulouse ; University Hospital Florence ;
Condition / Disease: Neuroendocrine tumours
Publication: Journal of Nuclear Medicine pjnumed.121.262561 Year: 2021 ORPHAcode / other: ORPHA877
DOI: 10.2967/jnumed.121.262561 Keywords: SIRT,neuroendocrine carcinoma,neuroendocrine neoplasm,neuroendocrine tumor,radioembolization,radionuclide therapy

Children with multiple endocrine neoplasia type 2B: Not tall and marfanoid, but short with normal body proportions


Author(s): van den Broek MFM, van Santen HM, Valk GD, Verrijn Stuart AA
Affiliated Institution / ERN: University Medical Center Utrecht ;
Condition / Disease: Multiple endocrine neoplasia type 2B
Publication: Clinical Endocrinology v95.3 p453-459 Year: 2021 ORPHAcode / other: ORPHA247709
DOI: 10.1111/cen.14536 Keywords: final height,growth,marfanoid body habitus,multiple endocrine neoplasia type 2B,short stature
MTG4

Adolescent and Young Adult Urogenital Outcome following Childhood Hypospadias Repair: Perfection Revisited


Author(s): Tack LJW, Springer A, Riedl S, Tonnhofer U, Hiess M, Weninger J, Mahmoud A, Van Laecke E, Hoebeke P, Cools M, Spinoit A
Affiliated Institution / ERN: Ghent University Hospital ; Medical University of Vienna,Center for Rare Diabetes and Congenital Hyperinsulinism / Dpt. of Pedia ; Medical University of Vienna,Center for Rare Endocrinologic Diseases / Dpt. of Internal Medicine III ;
Condition / Disease: Non-syndromic hypospadias
Publication: Journal of Urology v206.3 p734-744 Year: 2021 ORPHAcode / other: LB53
DOI: 10.1097/JU.0000000000001869 Keywords: hypospadias,treatment outcome,urologic surgical procedures, male

From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?


Author(s): Vitale G, Dicitore A, Barrea L, Sbardella E, Razzore P, Campione S, Faggiano A, Colao A, Albertelli M, Altieri B, Bottiglieri F, De Cicco F, Di Molfetta S, Fanciulli G, Feola T, Ferone D, Ferraù F, Gallo M, Giannetta E, Grillo F, Grossrubatscher E, Guadagno E, Guarnotta V, Isidori AM, Lania A, Lenzi A, Calzo FL, Malandrino P, Messina E, Modica R, Muscogiuri G, Pes L, Pizza G, Pofi R, Puliani G, Rainone C, Rizza L, Rubino M, Ruggieri RM, Sesti F, Venneri MA, Zatelli MC
Affiliated Institution / ERN: IRCCS Auxologico Italian Institute - Milan ; AO City of Health and Science - Turin ; Antonio Cardarelli Hospital - Naples ; ERN BOND ;
Condition / Disease: Neuroendocrine neoplasm
Publication: Reviews in Endocrine and Metabolic Disorders v22.3 p511-525 Year: 2021 ORPHAcode / other: ORPHA877
DOI: 10.1007/s11154-020-09589-y Keywords: Cytokines,Inflammation,Microbiota,Neuroendocrine tumors,Tumor microenvironment

Occurrence of pituitary hormone deficits in relation to both pituitary and hypothalamic doses after radiotherapy for skull base meningioma


Author(s): Partoune E, Virzi M, Vander Veken L, Renard L, Maiter D
Affiliated Institution / ERN: University Hospitals Saint-Luc ;
Condition / Disease: Meningioma
Publication: Clinical Endocrinology v95.3 p460-468 Year: 2021 ORPHAcode / other: ORPHA2495
DOI: 10.1111/cen.14499 Keywords: brain tumour,endocrine deficit,hypopituitarism,hypothalamus,pituitary,radiotherapy,skull base meningioma
MTG6

PRRT: identikit of the perfect patient


Author(s): Albertelli M, Dotto A, Di Dato C, Malandrino P, Modica R, Versari A, Colao A, Ferone D, Faggiano A
Affiliated Institution / ERN:
Condition / Disease:
Publication: Reviews in Endocrine and Metabolic Disorders v22.3 p563-579 Year: 2021 ORPHAcode / other:
DOI: 10.1007/s11154-020-09581-6 Keywords: Neuroendocrine tumors,Peptide receptor radionuclide therapy,Predictor,Response,Therapeutic sequence

The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause


Author(s): Robeva R, Mladenović D, Vesković M, Hrnčić D, Bjekić-Macut J, Stanojlović O, Livadas S, Yildiz BO, Macut D
Affiliated Institution / ERN: USHATE “ACAD IVAN Penchev” ;
Condition / Disease: NAFLD in postmenopausic women
Publication: Maturitas v151 p22-30 Year: 2021 ORPHAcode / other:
DOI: 10.1016/j.maturitas.2021.06.012 Keywords: dyslipidemia,estrogen,insulin resistance,menopausal hormonal therapy,menopause,non-alcoholic fatty liver disease

ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy


Author(s): A Luger, L H A Broersen, N R Biermasz, B M K Biller, M Buchfelder, P Chanson, J O L Jorgensen, F Kelestimur, S Llahana, D Maiter, G Mintziori, F Petraglia, R Verkauskiene, S M Webb, O M Dekkers
Affiliated Institution / ERN:
Condition / Disease:
Publication: European Journal of Endocrinology 185(3):G1-G33. doi: 10.1530/EJE-21-0462 Year: 2021 ORPHAcode / other:
DOI: Keywords:
MTG6

Outcome Squares Integrating Efficacy and Safety, as Applied to Functioning Pituitary Adenoma Surgery


Author(s): de Vries F, Lobatto DJ, Verstegen MJT, Schutte PJ, Notting IC, Kruit MC, Ahmed SF, Pereira AM, van Furth WR, Biermasz NR
Affiliated Institution / ERN: Leiden University Medical Center ;
Condition / Disease: Functioning pituitary adenoma
Publication: The Journal of Clinical Endocrinology & Metabolism v106.9 pe3300-e3311 Year: 2021 ORPHAcode / other: ORPHA314753
DOI: 10.1210/clinem/dgab138 Keywords: Pituitary adenoma,outcomes,patient counselling,transsphenoidal surgery
MTG6

Hyperprolactinemia in Adults with Prader-Willi Syndrome


Author(s): Sjöström A, Pellikaan K, Sjöström H, Goldstone AP, Grugni G, Crinò A, De Graaff LCG, Höybye C
Affiliated Institution / ERN: Karolinska University Hospital ; Erasmus MC: University Medical Center Rotterdam ; IRCCS Auxologico Italian Institute - Milan ;
Condition / Disease: Prader-Willi syndrome
Publication: Journal of Clinical Medicine v10.16 p3613 Year: 2021 ORPHAcode / other: ORPHA739
DOI: 10.3390/jcm10163613 Keywords: Prader-Willi syndrome,adults,hyperprolactinemia,hypogonadism
MTG5

Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study


Author(s): García-Escobar E, Valdés S, Soriguer F, Vendrell J, Urrutia-Etxebarria IM, Maldonado-Araque C, Ortega E, Ocón P, Montanya E, Menéndez E, Lago-Sampedro A, González-Frutos T, Gomis R, Goday A, García-Serrano S, Galán-García JL, Castell C, Bordiú E, Badía R, Aguilera-Venegas G, Girbés J, Gaztambide S, Delgado E, Chaves FJ, Castaño L, Calle-Pascual A, Rojo-Martínez G, Franch-Nadal J
Affiliated Institution / ERN: Hospital Universitario Cruces ;
Condition / Disease: Type 2 diabetes mellitus
Publication: Scientific Reports v11.1 Year: 2021 ORPHAcode / other: 5A10
DOI: 10.1038/s41598-021-95546-x Keywords:
MTG3
Page 19 of 32« First«...10...1718192021...30...»Last »

Endo-ERN Newsletter

Subscribe to our newsletter to receive updates on all network activities and new resources. As soon as you subscribe you will receive an email asking you to confirm your registration.

SIGN UP NOW

News

  • All news
  • Newsletter signup

Events

  • Upcoming events
  • Webinars

Information

  • About Us
  • Contact
  • FAQs

Social Links

Linkedin Facebook Youtube

Contact

Endo-ERN
Coordinating Center
Meibergdreef 9
1105 AZ AMSTERDAM
The Netherlands

info@endo-ern.eu
Funded by the European Union
©2026. All Rights Reserved. Endo-ERN

Privacy Policy – GDPR

Website design by Elan Creative

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Information video for patients and healthcare professionals

Type and Press “enter” to Search

Search
Privacy Overview
Endo-ERN

Endo-ERN Privacy Policy

Endo-ERN is committed to user’s privacy and does not track personal data when visiting our website. We act in accordance with Regulation 2016/679 of the European Parliament and of the Council.

‘Personal data’ means any information relating to an identified or identifiable natural person. An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as:

  • a name
  • an identification number
  • location data
  • an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person

Cookies

Endo-ERN only tracks anonymised data for statistical purposes. We do this via analytical cookies, placed through an anonymous IP Google analytics tag. The purpose of these cookies are to track the efficiency and success of the website.

These cookies do not store any personal data that can be linked to a natural person, but may save data such as inter alia, data about the website from which a person has come (the so-called referrer), which sub-pages were visited, or how often and for what duration a sub-page was viewed. The data collected through this is general data only, and cannot be traced back to one person.

It is possible to prevent the setting of cookies, by means of a setting of the Internet browser used. On top of that, already set cookies may be deleted at any time via an Internet browser or other software programs. This is possible in all popular Internet browsers.

Google Analytics does not share any data with third parties.

The principles of data protection do not apply to anonymous information and because these cookies minimally impact the privacy of the user, it is not necessary to ask for permission to use these cookies.

Newsletter

You may always unsubscribe from our newsletter at any time through the unsubscribe button located in our newsletter. Endo-ERN is both the controller and responsible for processing of any data regarding the newsletter. Endo-ERN does not make use of a third party for the Newsletter service.

E-services

Endo-ERN has a contact form, which activates your email software and allows you to send a comment or question to a general email address. When you send such a message, your personal data is collected only to the extent necessary to reply. If the team responsible for the mailbox is unable to answer your question, or your questions has regards to another party, it might forward your email to another service.

If you have any questions about the processing of your email and related personal data, do not hesitate to include them in your message.

The collected personal data and all information related to the above mentioned consultation is stored on the email server of the Endo-ERN Coordinating office and potentially those who have been concerned in the correspondence in order to respond to your comment.

Newsletter Tracking

The Endo-ERN newsletter makes use of tracking in order to be able to conduct a statistical analysis of the success or failure of online marketing campaigns. Endo-ERN may see if an email containing a newsletter was opened by a user, when it was opened, and which links were opened. 
The data collected through this tracking is generated and stored by Endo-ERN and is not shared with third parties, but may be used to adapt future content of newsletters in order to better meet the interests of our subscribers.

Contact details

For any questions regarding our privacy policy, please contact the Endo-ERN coordinating office.

You have the right to be forgotten and removed completely from the Endo-ERN contact database. To request this, please contact the Endo-ERN coordinating office.

Endo-ERN Coordinating Center, Meibergdreef 9, 1105 AZ  AMSTERDAM. The Netherlands

 info@endo-ern.eu
Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Powered by  GDPR Cookie Compliance